[{"NetIncomeLoss_2_Q2_USD":-42983000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":34353000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":16978000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":11350000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":4000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-137292000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":172365000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":172365000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":15000.0,"ProceedsFromMinorityShareholders_2_Q2_USD":18424000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":661000.0,"AssetsCurrent_0_Q2_USD":238481000.0,"PrepaidExpenseAndOtherAssets_0_Q2_USD":8435000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":9924000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":137236000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4195000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1044000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":4000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":4000.0,"CommonStockSharesIssued_0_Q2_shares":35878108.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":137175000.0,"Assets_0_Q2_USD":257217000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-42979000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-26853000.0,"ShareBasedCompensation_2_Q2_USD":8010000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2090000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":0.0,"ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_2_Q2_USD":14228000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":13065000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-544000.0,"LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":237925000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":512000.0,"ReclassificationsOfTemporaryToPermanentEquity_1_Q2_USD":155934000.0,"ReclassificationsOfTemporaryToPermanentEquity_2_Q2_USD":155934000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":30710000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":17452000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2404000.0,"AssetsFairValueDisclosure_0_Q2_USD":211321000.0,"AccountsReceivableNetCurrent_0_Q2_USD":73000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":36000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_security":14.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":8800000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":1212000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":38000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":76000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0_Q2_USD":137175000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":205134000.0,"RestrictedCash_0_Q2_USD":411000.0,"TemporaryEquityStockIssuedDuringPeriodValueNewIssues_2_Q2_USD":14228000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":96016000.0,"Liabilities_0_Q2_USD":19292000.0,"DeferredCosts_0_Q2_USD":0.0,"OperatingLeaseLiability_0_Q2_USD":2101000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PrepaidExpenseAndOtherAssetsNoncurrent_0_Q2_USD":3218000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-435000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":10002000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-27288000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":11.97,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":187000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":186000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":4000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":4000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":19000.0,"Goodwill_0_Q2_USD":3736000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-43527000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-27292000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7681000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":8010000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38904000.0,"NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_2_Q2_USD":18424000.0,"NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_1_Q2_USD":18424000.0,"LiabilitiesCurrent_0_Q2_USD":15567000.0,"RestrictedCashNoncurrent_0_Q2_USD":411000.0,"AccountsPayableCurrent_0_Q2_USD":4217000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5217000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":74146000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":74000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":15000.0,"AdditionalPaidInCapital_0_Q2_USD":339160000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":237925000.0,"MembersEquity_0_Q2_USD":213224000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":83400000.0,"PrepaidInsurance_0_Q2_USD":2435000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":2463000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":481000.0,"NetIncomeLoss_1_Q2_USD":-26857000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":96427000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":303000.0,"CommonStockSharesOutstanding_0_Q2_shares":35878108.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":28938000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4796000.0,"CommonStockSharesAuthorized_0_Q2_shares":250000000.0,"OperatingIncomeLoss_2_Q2_USD":-43775000.0,"OperatingIncomeLoss_1_Q2_USD":-27376000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":172482000.0,"InvestmentIncomeAmortizationOfPremium_2_Q2_USD":65000.0,"InvestmentIncomeInterest_2_Q2_USD":248000.0,"InvestmentIncomeInterest_1_Q2_USD":84000.0,"HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":127173000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":257217000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3025000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-67000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8010000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":667000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":810000.0,"OperatingExpenses_2_Q2_USD":43775000.0,"OperatingExpenses_1_Q2_USD":27376000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"ProfitLoss_1_Q2_USD":-27292000.0,"ProfitLoss_2_Q2_USD":-43527000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1262000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":56000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":137171000.0,"MembersEquityAttributableToNoncontrollingInterest_0_Q2_USD":24701000.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_Q2_shares":97241.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-125976000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":7681000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-43523000.0,"Ticker":"ZNTL","CIK":"1725160","name":"ZENTALIS PHARMACEUTICALS, INC.","OfficialName":"Zentalis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1133146413.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20200813"}]